CSTONE PHARMA-B (02616) plans to repurchase up to 136 million shares on the open market.
Kissey Pharmaceutical-B (02616) announced that, in accordance with the general authorization approved by the company's shareholders at the annual general meeting held on June 25, 2025, to repurchase shares, and (if applicable) any general authorization to repurchase shares approved by the company's shareholders at future shareholders' meetings from time to time (repurchase authorization), it plans to repurchase up to a maximum of 136 million shares on the open market from time to time.
CSTONE PHARMA-B (02616) announced that, pursuant to the general authorization for the repurchase of shares approved by the shareholders at the company's annual general meeting held on June 25, 2025, and any general authorization for the repurchase of shares approved by the shareholders at the company's future general meetings (if applicable), it intends to repurchase up to a maximum of 136 million shares on the open market.
The latest clinical data for the company's core product, CS2009 (PD-1/VEGF/CTLA-4 triple-specific antibody), will be announced at the ASCO annual meeting. Implementing the share repurchase plan in a timely manner will demonstrate the management team and board of directors' firm confidence in the company's research and development achievements, commercial progress, and long-term business development. It also reflects the company's high priority on shareholder value return and continuous improvement of the capital feedback mechanism.
Related Articles
InnoCare Pharma (09969): The Phase I clinical trial of ICP-054 (ZB021) has completed the enrollment of the first subject.
MICROTECH MED-B(02235) spent HKD 391,500 to repurchase 50,000 shares on May 13th.
CITIC BANK (00998) will distribute a final dividend of HKD 1.93 for every 10 shares on July 6th.
InnoCare Pharma (09969): The Phase I clinical trial of ICP-054 (ZB021) has completed the enrollment of the first subject.
MICROTECH MED-B(02235) spent HKD 391,500 to repurchase 50,000 shares on May 13th.
CITIC BANK (00998) will distribute a final dividend of HKD 1.93 for every 10 shares on July 6th.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
